Redalpine

What they fund

Companies at the intersection of software and science, from early-stage to growth [1]., Healthcare and digital health startups disrupting traditional systems [1]., AI infrastructure and molecular science platforms [1]., Pan-European founders with substantial engineering foundations [1]., GameChangers with clear societal value and technical moats [1].

Investment thesis

Redalpine invests at the intersection of software and science, backing founders who can bridge technical complexity with market impact. The firm operates as a multi-stage investment advisor with a thesis-driven approach, targeting frontier technologies where scientific breakthroughs meet substantial engineering foundations.

• Frontier Tech — Novel technologies and scientific breakthroughs built on substantial engineering foundations; primary risks are often technical, while market risks are lower due to clear societal value [1].
• Healthcare — Healthcare is one of the world's least digitalized sectors, poised for radical change driven by pioneering technologies [1].
• AI & Data — Foundational infrastructure for the AI era and missing data classes in molecular science [1].
• Digital Health — Moving digital health from wellness to clinical reality, disrupting traditional systems like credit and construction [1].

Credibility: The firm's homepage explicitly outlines its multi-stage approach and core belief in the connection between software and science [1].

Value add

Redalpine provides strategic and hands-on support, leveraging a team composed of half scientists and half operators to understand highly technical companies and speak to founders on eye level [1].

Fit verdict: Ideal for deep-tech and science-heavy founders needing technical validation and pan-European network access.

Founder diligence script:

• How does Redalpine's scientific team contribute to technical due diligence?
• What is the typical follow-on investment posture for Series A+ rounds?
• How does the firm support portfolio companies in expanding across Europe?
• What specific operational support is provided to healthcare startups navigating regulatory hurdles?

Portfolio focus

N26 (Digital banking, Series E), Inkitt (Content platform, Series B), Taxfix (Tax software, Series D), Zenjob (Workforce platform, Growth Round), 011h (Construction tech, Series A)

Notable investments & exits

N26 (Series E, $900m) - Digital banking [1]., Inkitt (Series B, $59m) - Content platform [1]., Taxfix (Series D, $220m) - Tax software [1]., Zenjob (Growth Round, $50m) - Workforce platform [1]., 011h (Series A, €25m) - Construction tech [1].

Strategic implications

Redalpine's unique team composition (scientists and operators) provides a competitive edge in evaluating deep-tech and science-heavy startups, reducing technical risk perception. The pan-European focus allows for cross-border scaling support, a key differentiator in the fragmented European market. The firm's thesis-driven approach may limit diversification but enhances conviction in high-impact sectors like healthcare and AI.

Where they could go further

Expand focus to include more climate tech and sustainability startups, aligning with global ESG trends and leveraging scientific expertise., Develop a more structured follow-on investment strategy to support portfolio companies through multiple funding rounds, enhancing long-term value creation., Increase visibility into co-investment activities and LP disclosures to attract more institutional capital and build transparency., Enhance operational support for healthcare startups navigating regulatory hurdles, providing dedicated resources for compliance and market access.